Cargando…
2897. Collocated Buprenorphine Is Associated with Improved HCV Visit Adherence in People Who Inject Drugs (PWID): Data From the ANCHOR Study
BACKGROUND: Engaging PWID in HCV treatment and monitoring for reinfection is critical to eliminate HCV and improve health in people who use drugs. However, PWID are often marginalized and can be difficult to engage and retain in care. The collocation of HCV treatment with buprenorphine to treat opio...
Autores principales: | Rosenthal, Elana S, Silk, Rachel, Mathur, Poonam, Eyasu, Rahwa, Nussdorf, Laura, Hill, Kristi, D’Amore, Aaron, Brokus, Christopher, Bijole, Phyllis, Jones, Miriam, Kier, Randy, Sternberg, David, Masur, Henry, Kottilil, Shyam, Kattakuzhy, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808822/ http://dx.doi.org/10.1093/ofid/ofz359.175 |
Ejemplares similares
-
2900. High Rates of Experienced and Witnessed Opioid Overdose in PWID Receiving HCV Treatment: Data From the ANCHOR Study
por: Rosenthal, Elana S, et al.
Publicado: (2019) -
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment
por: Brokus, Christopher, et al.
Publicado: (2021) -
859. Suboptimal Uptake, Retention, and Adherence of Daily Oral PrEP Among People with OUD Receiving HCV Treatment
por: Brokus, Christopher J, et al.
Publicado: (2021) -
298. Collocation of Hepatitis C Care Continuum with MAT for High-Prevalence, High-Risk Population
por: Narayanan, Shivakumar, et al.
Publicado: (2019) -
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV
por: Hill, Kristi C, et al.
Publicado: (2022)